CFI Gene - Complement Factor I

Key regulator of the complement system, associated with atypical hemolytic uremic syndrome and complement deficiencies.

Gene Information Card

Symbol CFI
Full Name Complement Factor I
Gene Type protein-coding
Chromosomal Location 4q25
NCBI Gene ID 3426 ncbi.nlm.nih.gov/gene/3426
Ensembl ID ENSG00000105403
UniProt ID P05156
OMIM ID 217030
HGNC ID 2154
Aliases C3b/C4b inactivator, FI, IF

Description

The CFI gene encodes complement factor I, a serine protease that regulates the complement cascade by cleaving C3b and C4b in the presence of cofactors. This prevents excessive complement activation and tissue damage. Mutations in CFI are associated with atypical hemolytic uremic syndrome (aHUS), complement factor I deficiency, and age-related macular degeneration.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Atypical Hemolytic Uremic Syndrome (aHUS) Loss-of-function mutations reduce factor I activity, leading to uncontrolled complement activation on endothelial cells, causing thrombotic microangiopathy. ClinVar, OMIM
Complement Factor I Deficiency Biallelic mutations cause complete or partial deficiency, resulting in recurrent infections due to impaired opsonization and immune complex clearance. OMIM, NCBI
Age-Related Macular Degeneration (AMD) Certain CFI variants (e.g., rs10033900) are associated with altered complement regulation in the retina, contributing to drusen formation. NCBI, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Blood 8.3 Medium
Kidney 4.1 Low
Lung 2.7 Low
Brain 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 15.0 High expression
K-562 (leukemia) 6.5 Medium expression
HeLa (cervical) 3.0 Low expression
A549 (lung) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1420C>T (p.Arg474Ter) Nonsense <0.01% Loss of function; truncation of serine protease domain
c.772G>A (p.Gly258Arg) Missense 0.02% Loss of function; impaired catalytic activity
c.1072T>C (p.Tyr358His) Missense 0.01% Loss of function; reduced secretion and activity
c.1654G>A (p.Gly552Arg) Missense 0.005% Loss of function; disrupts cofactor binding
Mutation functional classification

Loss of Function (LOF)

Most CFI mutations are loss-of-function, reducing or abolishing factor I activity, leading to uncontrolled complement activation.

Gain of Function (GOF)

No gain-of-function mutations are reported in CFI.

Dominant Negative (DN)

Dominant-negative effects are not described for CFI mutations; disease typically follows a recessive or haploinsufficient pattern.

Pathways

Complement cascade (Reactome: R-HSA-166658)
Regulation of complement cascade (Reactome: R-HSA-977606)

Protein Summary

Complement factor I is a 88 kDa serine protease synthesized primarily in the liver and secreted into plasma. It consists of a heavy chain (containing a factor I membrane attack complex domain and a scavenger receptor cysteine-rich domain) and a light chain (serine protease domain). Factor I cleaves C3b and C4b in the presence of cofactors (e.g., factor H, MCP, C4BP), downregulating the complement cascade. Deficiency or dysfunction predisposes to complement-mediated diseases.

Related Products

Product name Cat.No. Species Gene ID
CFI Knockout HEK293 Cell Line EDJ-KQ50378 Human 3426 Details Get a Quote
CFI Knockout HeLa Cell Line EDJ-KQ53606 Human 3426 Details Get a Quote
CFI Knockout A-549 Cell Line EDJ-KQ62075 Human 3426 Details Get a Quote
CFI Knockout HCT 116 Cell Line EDJ-KQ70557 Human 3426 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: